Altered Serum Interleukin-7 and Interleukin-10 Are Associated with Drug-free Major Depressive Disorder

Overview

Journal Ther Adv Psychopharmacol

Specialty Psychiatry

Date 2020 May 22

PMID 32435448

Citations 36

Authors

Sadia Anjum

M M A Shalahuddin Qusar

Mohammad Shahriar

Sardar Mohammad Ashraful Islam

Mohiuddin Ahmed Bhuiyan

Md Rabiul Islam

Affiliations

Soon will be listed here.

Abstract

Background: Abnormal expression of inflammatory cytokines in major depressive disorder (MDD) suggests the activation of an inflammatory process. The pattern of alterations in cytokine levels is still ambiguous. The present study aimed to evaluate interleukin-7 (IL-7) and interleukin-10 (IL-10) for their involvement in the pathophysiology of MDD and determine their relationships with depression risk.

Methods: The study included 166 medication-free subjects: 84 MDD patients and 82 sex- and age-matched healthy controls (HCs). A qualified psychiatrist diagnosed patients and evaluated controls based on the , 5th edition (DSM-5). Hamilton depression rating scale (Ham-D) was used to measure the severity of depression in MDD patients. Serum IL-7 and IL-10 levels were measured using enzyme-linked immunosorbent assay (ELISA) kits.

Results: Compared with HCs, the serum levels of IL-7 were significantly decreased, whereas that of IL-10 increased in MDD patients. Moreover, the severity of depression is correlated with the altered levels of IL-7 and IL-10 in MDD patients. We found a negative correlation between IL-7 and Hamilton depression rating (Ham-D) scores ( = -0.580, < 0.05), whereas there was a positive correlation between IL-10 and Ham-D scores (= 0.555, < 0.05).

Conclusions: The altered levels of serum IL-7 and IL-10 in MDD patients may represent a homeostatic mechanism that enhances the inflammatory process during depression. The alterations of these cytokine levels in MDD and their association with the severity of depression support them as promising, but there may still be controversial factors for understanding the pathophysiology of depression.

Citing Articles

Comprehensive view of suicide: A neuro-immune-endocrine approach.

Ponce-Regalado M, Becerril-Villanueva E, Maldonado-Garcia J, Moreno-Lafont M, Martinez-Ramirez G, Jacinto-Gutierrez S World J Psychiatry. 2025; 15(2):98484.

PMID: 39974471 PMC: 11758041. DOI: 10.5498/wjp.v15.i2.98484.

New insights into roles of IL-7R gene as a diagnostic biomarker for post-stroke depression.

Liu M, Sun H, Yao Q, Wang D, Zhang J, Ye X Front Immunol. 2025; 15:1506214.

PMID: 39763672 PMC: 11700794. DOI: 10.3389/fimmu.2024.1506214.

Increased serum EGF but not SDF-1 levels are associated with the pathophysiology and development of generalized anxiety disorder.

Roknuzzaman A, Qusar M, Shahriar M, Islam S, Islam M Sci Rep. 2024; 14(1):27409.

PMID: 39521929 PMC: 11550425. DOI: 10.1038/s41598-024-79166-9.

The correlation of inflammation, tryptophan-kynurenine pathway, and suicide risk in adolescent depression.

Yang S, Han J, Ye Z, Zhou H, Yan Y, Han D Eur Child Adolesc Psychiatry. 2024; .

PMID: 39287643 DOI: 10.1007/s00787-024-02579-4.

Differences in bacterial taxa between treatment-naive patients with major depressive disorder and non-affected controls may be related to a proinflammatory profile.

Knudsen J, Bundgaard-Nielsen C, Leutscher P, Hjerrild S, Nielsen R, Sorensen S BMC Psychiatry. 2024; 24(1):84.

PMID: 38297265 PMC: 10832199. DOI: 10.1186/s12888-024-05547-z.

References

Nolen-Hoeksema S, Girgus J . The emergence of gender differences in depression during adolescence. Psychol Bull. 1994; 115(3):424-43. DOI: 10.1037/0033-2909.115.3.424. View

Brunoni A, Machado-Vieira R, Zarate C, Valiengo L, Vieira E, Bensenor I . Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial. Psychopharmacology (Berl). 2013; 231(7):1315-23. PMC: 4081040. DOI: 10.1007/s00213-013-3322-3. View

Schwarz E, Guest P, Rahmoune H, Harris L, Wang L, Leweke F . Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2011; 17(5):494-502. DOI: 10.1038/mp.2011.42. View

Caspi A, Sugden K, Moffitt T, Taylor A, Craig I, Harrington H . Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003; 301(5631):386-9. DOI: 10.1126/science.1083968. View

Murray C, Vos T, Lozano R, Naghavi M, Flaxman A, Michaud C . Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2197-223. DOI: 10.1016/S0140-6736(12)61689-4. View

Anisman H, Merali Z, Hayley S . Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol. 2008; 85(1):1-74. DOI: 10.1016/j.pneurobio.2008.01.004. View

Grosse L, Hoogenboezem T, Ambree O, Bellingrath S, Jorgens S, de Wit H . Deficiencies of the T and natural killer cell system in major depressive disorder: T regulatory cell defects are associated with inflammatory monocyte activation. Brain Behav Immun. 2015; 54:38-44. DOI: 10.1016/j.bbi.2015.12.003. View

Talarowska M, Szemraj J, Galecki P . The role of interleukin genes in the course of depression. Open Med (Wars). 2017; 11(1):41-48. PMC: 5329796. DOI: 10.1515/med-2016-0009. View

Toussi S, Pan N, Walters H, Walsh T . Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature. Clin Infect Dis. 2013; 57(9):1318-30. PMC: 3888230. DOI: 10.1093/cid/cit489. View

10.

Connor T, Leonard B . Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 1998; 62(7):583-606. DOI: 10.1016/s0024-3205(97)00990-9. View

11.

Miller A . Depression and immunity: a role for T cells?. Brain Behav Immun. 2009; 24(1):1-8. PMC: 2787959. DOI: 10.1016/j.bbi.2009.09.009. View

12.

Simon N, McNamara K, Chow C, Maser R, Papakostas G, Pollack M . A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol. 2007; 18(3):230-3. PMC: 2267745. DOI: 10.1016/j.euroneuro.2007.06.004. View

13.

Iacob E, Light K, Tadler S, Weeks H, White A, Hughen R . Dysregulation of leukocyte gene expression in women with medication-refractory depression versus healthy non-depressed controls. BMC Psychiatry. 2013; 13:273. PMC: 4015603. DOI: 10.1186/1471-244X-13-273. View

14.

Breslau N . Depressive symptoms, major depression, and generalized anxiety: a comparison of self-reports on CES-D and results from diagnostic interviews. Psychiatry Res. 1985; 15(3):219-29. DOI: 10.1016/0165-1781(85)90079-4. View

15.

Tang Z, Ye G, Chen X, Pan M, Fu J, Fu T . Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder. J Affect Disord. 2017; 225:593-598. DOI: 10.1016/j.jad.2017.08.082. View

16.

Rawdin B, Mellon S, Dhabhar F, Epel E, Puterman E, Su Y . Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun. 2012; 31:143-52. PMC: 3669232. DOI: 10.1016/j.bbi.2012.11.011. View

17.

Henry C, Huang Y, Wynne A, Godbout J . Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun. 2008; 23(3):309-17. PMC: 2692986. DOI: 10.1016/j.bbi.2008.09.002. View

18.

Nishuty N, Khandoker M, Karmoker J, Ferdous S, Shahriar M, Qusar M . Evaluation of Serum Interleukin-6 and C-reactive Protein Levels in Drug-naïve Major Depressive Disorder Patients. Cureus. 2019; 11(1):e3868. PMC: 6414189. DOI: 10.7759/cureus.3868. View

19.

Dahl J, Ormstad H, Aass H, Malt U, Traskman Bendz L, Sandvik L . The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology. 2014; 45:77-86. DOI: 10.1016/j.psyneuen.2014.03.019. View

20.

Paul S, Lal G . The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy. Front Immunol. 2017; 8:1124. PMC: 5601256. DOI: 10.3389/fimmu.2017.01124. View